Biocompatible Shape Morphing Hydrogel Actuators
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current hydrogel actuators for tissue engineering lack biocompatibility, cytotoxicity, and the ability to undergo multiple, reversible, and controllable shape transformations, limiting their application in replicating dynamic tissue morphogenesis.
Innovation Solution
Development of biocompatible and cytocompatible polymer-based shape morphing hydrogels and cell condensates that enable multiple, reversible, and controllable shape transformations under physiological conditions, using layers with varying swelling and degradation rates, and incorporating acrylated and methacrylated polymer macromers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If traditional hydrogel actuators are used for shape morphing, then shape transformation capability is achieved, but biocompatibility and cytotoxicity are compromised
Solution Approach 1:
The patent changes the chemical composition parameters of the hydrogel from traditional non-biocompatible materials (like PEGDA) to biocompatible natural polymers (alginate, gelatin, collagen, hyaluronic acid). This parameter change enables the hydrogel to undergo shape morphing while maintaining biocompatibility and eliminating cytotoxicity, thus resolving the contradiction between shape transformation capability and harmful factors.
Solution Approach 2:
The patent employs composite hydrogel systems combining multiple biocompatible polymers (e.g., alginate-gelatin, collagen-hyaluronic acid) with integrated cell-laden zones. These composite materials achieve both the required shape morphing functionality and biocompatibility, as the natural polymer matrix provides a non-toxic environment for cells while the layered composite structure enables controlled shape transformations.
2Ease of manufacture
If single-stage shape change hydrogels are used, then fabrication simplicity is maintained, but controllability and reversibility are limited
Solution Approach 1:
The patent divides the hydrogel into multiple functional layers with distinct properties: some layers are designed for swelling-induced shape change, others for degradation-controlled morphing, and specific zones for cell encapsulation. This segmentation enables multi-stage, reversible shape transformations while maintaining fabrication simplicity through a layered construction approach that can be assembled from standardized components.
Solution Approach 2:
The patent introduces dynamic controllability by designing hydrogels that can switch between different shape states in response to environmental stimuli (pH, temperature, enzymatic degradation). The system transitions from static single-stage shape change to dynamic multi-stage reversible transformations, where each layer can be activated independently to achieve programmable shape morphing sequences.
3Adaptability or versatility
If harsh conditions are used to activate shape responses, then shape transformation is achieved, but cell viability is compromised
Solution Approach 1:
The patent introduces biocompatible intermediaries that mediate between the shape morphing mechanism and the cells. Instead of directly exposing cells to harsh chemicals or extreme pH/temperature conditions, the system uses natural polymer degradation products and physiological stimuli (body temperature, pH gradients) as intermediaries to trigger shape changes. This intermediary approach enables shape transformation activation while protecting cell viability.
4Strength
If PEG-based hydrogels are used for cell encapsulation, then mechanical integrity is improved, but biocompatibility deteriorates
Solution Approach 1:
The patent replaces PEG-based synthetic hydrogels with composite systems of natural polymers (alginate, gelatin, collagen, hyaluronic acid) that inherently provide both mechanical integrity and biocompatibility. These natural polymer composites form cell-laden zones with appropriate mechanical properties for cell encapsulation while eliminating the cytotoxicity associated with PEG materials, thus resolving the contradiction between strength and biocompatibility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The developed hydrogels and cell condensates facilitate defined self-folding and user-regulated shape changes, mimicking complex developmental processes, and are suitable for promoting new complex tissue formation and regenerative medicine applications.
Implementation Method 1
layers with varying swelling and degradation rates
Implementation Method 2
layers with varying swelling and degradation rates
Data Source
AI summary
A construct includes a biocompatible polymer-based shape morphing hydrogel or cell condensate that is configured to undergo multiple, reversible, and/or controllable different shape transformations over time via either pre-programmed design or user-controlled environmental condition alterations, wherein the hydrogel is cytocompatible and, upon degradation, produces substantially non-toxic products.